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Abstract
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is characterized by a loss of distal peripheral sensory and
motorneuronal function, neuropathic pain and tissue necrosis. The most common cause of HSAN1 is due to dominant
mutations in serine palmitoyl-transferase subunit 1 (SPT1). SPT catalyses the condensation of serine with palmitoyl-CoA, the
initial step in sphingolipid biogenesis. Identiﬁed mutations in SPT1 are known to both reduce sphingolipid synthesis and
generate catalytic promiscuity, incorporating alanine or glycine into the precursor sphingolipid to generate a deoxysphingoid
base (DSB).Whyeither loss of function in SPT1, or generation of DSBs should generate deﬁcits in distal sensory function remains
unclear. To address these questions, we generated a Drosophilamodel of HSAN1. Expression of dSpt1 bearing a disease-related
mutation inducedmorphological deﬁcits in synapse growth at the larval neuromuscular junction consistent with a dominant-
negative action. Expression of mutant dSpt1 globally was found to be mildly toxic, but was completely toxic when the diet was
supplementedwith alanine,whenDSBswere observed in abundance. Expression ofmutant dSpt1 in sensory neurons generated
developmental deﬁcits in dendritic arborization with concomitant sensory deﬁcits. A membrane trafﬁcking defect was
observed in soma of sensory neurons expressing mutant dSpt1, consistent with endoplasmic reticulum (ER) to Golgi block.
We found that we could rescue sensory function in neurons expressing mutant dSpt1 by co-expressing an effector of ER–Golgi
function, Rab1 suggesting compromised ER function in HSAN1 affected dendritic neurons. Our Drosophilamodel identiﬁes a
novel strategy to explore the pathological mechanisms of HSAN1.
Introduction
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is
a rare disorder pathologically characterized by distal sensory loss
and peripheral ulceration, predominantly in lower limbs (1–5).
Degeneration ofmotorneurons is also known to occur in addition
to distal limb weakness and muscle atrophy (4). The condition is
caused in the majority of cases by inheritable dominant muta-
tions in the genes encoding subunits of the enzyme serine palmi-
toyl-transferase (SPT). SPT function is essential for catalysis of
the ﬁrst step in de novo sphingolipid synthesis at the ER (6,7).
SPT exists as a heterodimer of homologous subunits, SPT long
chain base subunit 1 (SPTLC1/SPT1) and SPT long chain base
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subunit 2 (SPTLC2/SPT2), that catalyse the pyridoxal phosphate-
dependent condensation of -serine and palmitoyl-coenzyme-A
to generate 3-ketosphinganine (8). A third subunit present in
mammals, SPTLC3 contributes to the generation of short C16
sphingoid bases (9). At present, the manner in which the domin-
ant mutations in SPT1 affect neuronal function, particularly in
peripheral nerves, is unclear.
A number of HSAN1-related missense mutations (C133W,
C133Y and V144D) have been identiﬁed in SPT1 from 24 affected
families (6,7) ofwhich C133Wappears to be themost common (7).
More recently, mutations in SPT2 that cause a form of HSAN1
have been identiﬁed (10,11). A structural determination of the
homologous prokaryotic enzyme, which exists as a homodimer,
has given some insight into how disease mutations may affect
the activity of the enzyme (8,12). Initially, reports suggested
that disease-related mutations in SPT1 generated a gain-of-
functionmechanism in SPT resulting in increased cellular gluco-
sylceramide levels (7). Others suggested a dominant-negative
mechanism, albeit amechanism of selective or reduced sphingo-
lipid synthesis while overall sphingolipid levels weremaintained
(13,14). Recent data, however, have suggested that the SPT1 dis-
ease causing mutations may be neomorphic and cause a shift
in substrate speciﬁcity from serine to alanine or glycine incorpor-
ation (15,16). This in turn generates atypical unmodiﬁable deoxy-
sphingoid bases (DSBs) which, based on their in vitro activity, are
proposed to be neurotoxic (15,16).Whether themutations act in a
predominantly neomorphic (production of toxic DSBs) or domin-
ant-negative (reduction of sphingolipid synthesis) manner, or if
the two mechanisms overlap to generate pathology remain un-
clear. Why peripheral neurons are predominantly affected by
mutations in this enzyme similarly remains unexplained.
To understand the pathological function of HSAN1mutations
in SPT1, and the possible toxic effect of dietary alanine in vivo, we
have employed a transgenic approach using the genetically tract-
able Drosophila larval peripheral nervous system as a model sys-
tem. Using a novel nociception assay (17), selective enrichment
of amino acids in the diet and examination of membrane trafﬁc
in sensory neurons, we determined a direct relationship between
the disease mutations, dietary alanine, the presence of DSBs
and sensory function. Additionally we identify a potential patho-
logical mechanism of disrupted ER to Golgi trafﬁc in these
neurons. Our ﬁndings suggest a novel mechanism for sensory
dysfunction that is consistent with deﬁcits in distal peripheral
neurons and further highlight a critical functional role for the
secretory system in peripheral dendritic processes.
Results
dSpt1 is an essential gene in Drosophila
HSAN1 is caused bymutations in the SPTLC1 gene, themost com-
monmutation being C133W (6,7). The SPTLC1 gene encodes SPT1,
which localizes to the ERmembrane and associates with cytosol-
ic SPT2 to form the type 1 ER protein SPT (18). SPT performs the
initial step in de novo sphingolipid synthesis, catalysing the con-
densation of -serine and palmitoyl-coA to form ketosphinga-
nine. Position C133 shows a high degree of evolutionary
conservation (Fig. 1A) and lies within a highly conserved protein
domain that has been linked to critical roles in SPT activity and
substrate speciﬁcity (8).
To aid our analysis, we identiﬁed alleles of Drosophila dSpt1.
From the Drosophila genome project and Bloomington stock cen-
tre, we identiﬁed a P-element insertion in the 5′ regulatory region
of dSpt1, dSpt1l(2)SH1626 (19). When crossed to a deﬁciency stock
uncovering the region, Df(2)vg-B, we found that development of
the P-element/deﬁciency transheterozygotes was delayed by
3–5 days.We used this delayed eclosion phenotype to screen pre-
viously identiﬁed but unsequenced point mutations from the
genomic region in dSpt1. We identiﬁed two point mutations l(2)
49Fb1 and l(2)49Fb4 in the dSpt1 locus (20). Sequencing of the
dSpt1 locus in l(2)49Fb1 allele revealed a C251Y nonsense muta-
tion, while sequencing of the l(2)49Fb4 allele uncovered a Q90–
STOP truncation. Furthermore, we used a P-element imprecise
excision strategy to delete 1.6 kb (including the start codon) of
the dSpt1 locus and generate the dSpt1JO8 allele (Supplementary
Material, Fig. S1). When the dSpt1l(2)SH1626 mutant was crossed
to the l(2)49Fb4, l(2)49Fb1 or dSpt1JO8 alleles, all mutant combina-
tions were found to have the 3–5 day delayed development
phenotype. Complementation crosses of l(2)49Fb4, l(2)49Fb1 and
dSpt1JO8 to each other were lethal at ﬁrst instar, conﬁrming our
dSpt1l(2)SH1626 allele as an dSpt1 hypomorph. Global expression
of the UAS-dSpt1 transgene under the control of tubulin-GAL4
was also sufﬁcient to rescue all transheterozygous dSpt1mutant
combinations, allowing survival to adulthood. Neuronal (Elav-
GAL4) or muscle (MHC-GAL4) driven expression of UAS-dSpt1
failed to rescue dSpt1 mutants to adulthood. We can therefore
conclude that the dSpt1 locus, like the dSpt2 locus (lace) (21), is
an essential gene in Drosophila and required globally.
dSpt1C129W acts in a dominant-negative manner at the
Drosophila larval neuromuscular synapse to alter synapse
growth parameters
HSAN1 patients have peripheral- and motorneuronal functional
deﬁcits (4). To try to dissect the mechanism driving SPT1C133W
dysfunction in motor neurons, we examined the effects of ex-
pression of amutatedDrosophila SPT1 protein at the larval neuro-
muscular synapse.
We obtained the cDNA of the Drosophila SPT1 (dSpt1), intro-
duced a C to W substitution at amino acid position 129 (analo-
gous to the human 133, Fig. 1A) by site-directed-mutagenesis
and subcloned both the wild-type and mutant subunit into the
pUASt vector (22). We generated multiple independent UAS-
dSpt1 and UAS-dSpt1C129W transgenes by microinjection, allow-
ing us to express both forms in a tissue-speciﬁc manner under
the control of the GAL4 transcriptional activator. When ex-
pressed with ppk-GAL4, all UAS-dSpt1-C129W transgenes
generated a defective nociception response (see Fig. 2), while ex-
pression of UAS-dSpt1 gave responses no different to wild-type
animals.
To ascertain the effect of dSpt1C129W expression on neuronal
growth, we expressed the dSpt1C129W protein in the nervous sys-
tem of the developing Drosophila larva using the pan-neuronal
Elav-GAL4 driver and examined the effect on third instar neuro-
muscular junction (NMJ)morphology (Fig. 1B andC). TheDrosoph-
ila larval NMJ is a genetically tractable and accessible model
glutamatergic synapse that is well characterized for growth and
morphology (23,24). Using homozygotes of a previously isolated
hypomorphic allele of dSpt2, dSpt2/laceP (21) with a sphingolipid
content known to be 2.58% ofwild-type levels (25) we determined
that a loss of SPT activity generated a reduction in synaptic bou-
ton number, reducing bouton number by 50%.
Pan-neuronal (Elav-GAL4) expression of UAS-dSpt1C129W re-
sulted in no change in synaptic bouton number at the larvalmus-
cle 6/7, hemisegment A3 NMJ (Fig. 1B and C). Introduction of
heterozygous alleles of dSpt1, or dSpt2/lace in the presence of glo-
bally expressed dSpt1C129W-induced lethality at pupal stage.
Introduction of heterozygous alleles of dSpt1 or dSpt2/laceP in
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the presence of theneuronally expressed dSpt1C129W induced a re-
duction of bouton number of 50%, phenocopying the homozy-
gous loss-of-function allele of dSpt2/laceP (Fig. 1B and C). This
genetic interaction between dSpt1C129W expression and heterozy-
gous mutations of dSpt1 and dSpt2/laceP strongly suggests a dom-
inant-negative function for the dSpt1C129W mutation when
examined in the context of lethality and synaptic growth.
dSpt1C129W expression in sensory neurons of Drosophila
larvae induces a sensory deﬁcit
HSAN1 manifests as distal sensory loss, allowing recurrent and
progressive tissue damage due to injury. We probed our Drosoph-
ilamodel of HSAN1 for any effect in the response to noxious heat
stimuli. It has been shown previously that in response to noxious
Figure 1. Spt1C129Wacts as a genetic dominant negative to alter synaptic growth parameters. (A) C133W/Yare themost commonHSAN1-causingmutations. C133 and itsﬂy
orthologue C129 are highly conserved and lie within a highly conserved protein domain. Accession numbers: Homo sapiens AAH68537, Drosophila melanogaster AAM68597,
Caenorhabditis elegans P91079, Dictyostelium discoideum Q55FL5.1, Arabidopsis thalania CAB16844 and Saccharomyces cerevisiae AAA34739. Red asterisk indicates the site of
V144D mutations that also give rise to HSAN1. (B) Global disruption of Spt1 function using mutants of Spt2/lace and neuronal expression (Elav-GAL4) of UAS-Spt1C129W
transgenes, in combination with an Spt1 mutant (Spt1l(2)SH1626), disrupt NMJ growth parameters at the 6/7 muscle, hemisegment A3. Scale bar = 10 µm. (C)
Quantiﬁcation of growth parameters at neuromuscular synapse 6/7 hemisegment A3. ****P≤ 0.0001.
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heat thresholds, third instar larvae perform a rapid and charac-
teristic barrel-rolling escape behaviour. This behavioural re-
sponse was previously used to identify the painless mutant (28).
We recently developed a novel thermosensation/nociception
assay based on this rolling behaviour elicited by excessive heat
in a droplet of water and used it to askwhether third instar larvae
expressing dSpt1C129W in the class IV da neurons showa defective
noxious heat response (17). Expression of dSpt1C129W signiﬁcantly
increased the nociceptive response temperature (Fig. 2), suggest-
ing that dSpt1C129W expression in the class IV da neurons is sufﬁ-
cient to perturb nociception. The painless mutant and the
expression of tetanus-toxin light chain in the class IV da neurons
showa similar delayed response. The expression of tetanus toxin
light chain, shown previously to promote synapse silencing (29),
produces a shift in nociceptive response temperature but like the
pain1mutant and the dSpt1C129Wmanipulation does not remove it
completely; most likely due to the presence of other thermosen-
sors tuned to proximate temperature ranges in the peripheral
nervous system (30). These data reveal that the class IV da neu-
rons contribute signiﬁcantly, but not exclusively, to the larval re-
sponse to heat, and that dSpt1C129W expression in class IV da
neurons compromises this response while dSpt1 expression pro-
duces a response indistinguishable from wild-type animals. To
probe the functional integrity of the central synapses of the
Class IV sensory neurons in larvae, we co-expressed a channelr-
hodopsin construct (31) with dSpt1C129W using the ppk-GAL4 dri-
ver (32). Light activation of the channelrhodopsin elicited a
nocifensive escape response in the presence of dSpt1C129W sug-
gesting that the synapses of the class IV sensory neurons are
still able to function (Supplementary Material, Movie S1). We ex-
amined themorphology of the synapses of the Class IV dendritic
neurons in the larval ventral nerve cord when either dSpt1 or
dSpt1C129W are expressed with the ppk-GAL4 driver (Supplemen-
taryMaterial, Fig. S2).We observedno grossmorphological differ-
ences in synapse structure between dSpt1, dSpt1C129W expressing
animals and wild-type. We conclude from this series of experi-
ments that the sensory dendrite function of class IV da neurons
are likely to be compromised by dSpt1C129W expression.
In the presence of dSpt1C129W, enrichment of alanine in
the larval diet is toxic and can be partially alleviated by
increasing serine dietary abundance
The discovery of possible substrate promiscuity in the SPT en-
zyme complexes bearing HSAN1 mutations (15,16) proposed a
novel, neomorphic mechanism for dSpt1C129W toxicity. Cysteine
133 of SPT1 associates intimately with lysine 265 in SPT2 upon
heterodimer assembly. It is proposed that the substitution of a
large tryptophan residue compromises SPT2 lysine 265 function
and perturbs Schiff base association with the SPT co-factor pyri-
doxal-5-phosphate. The occlusion of the active site is proposed to
allow the entry of smaller amino acids such as alanine and gly-
cine in preference to serine (15,16). Addition of alanine or glycine
to palmitoyl-CoA generates a deoxyspingoid base that cannot be
further modiﬁed to generate normally biologically active and di-
verse sphingolipid species. This ﬁnding suggests that an enrich-
ment of alanine or glycine in the diet of larvae expressing the
dSpt1C129W protein should be toxic.
We raised larvae globally expressing either wild-type dSpt1 or
dSpt1C129W on diets containing 10 m or 100 m alanine. We
found enriched alanine to be 100% toxic to larvae expressing
dSpt1C129W, but not animals expressing wild-type dSpt1, control
wild-type animals or siblings bearing a balancer chromosome
(and therefore lacking the tubulin-GAL4 element to drive expres-
sion of dSpt1 or dSpt1C129W) (Fig. 3A and B). Toxicity of alanine for
animals expressing dSpt1C129W protein could be partially alle-
viated by co-feeding 100 m serine. Serine feeding had no effect
on animals expressing either the wild-type dSpt1 or dSpt1C129W
protein in the absence of alanine supplementation. On normal
lab yeast/agar food, survival for larvae expressing dSpt1C129W is
unaffected (data not shown). Raising larvae on ‘instant’ labora-
tory food reduces survival for dSpt1C129W expressing larvae
suggesting a high content of alanine or glycine (Fig. 3B). Supple-
menting ‘instant’ food with 100 m serine brings survival of
dSpt1C129Wexpressing larvae towild-type levels. Our data support
the ﬁndings that alanine is toxic in the presence of an HSAN1
mutation in SPT1.
Global expression of dSpt1C129W generates a reduction of
normal sphingolipids, and upon feeding of alanine
reveals the presence of DSBs
We interrogated our model of HSAN1 by globally expressing
dSpt1C129W and assessed the abundance of sphingolipids. As
can be seen in the graph (Fig. 3C and D), total sphingoid base
abundance is reduced in animals globally expressing dSpt1C129W
compared with controls, while the content of DSBs is only mar-
ginally elevated in the dSpt1C129W animals grown on normal lab
food (with no DSBs found in the wild-type animals), suggesting
a dominant-negative effect of this mutation on sphingolipid bio-
synthesis. However, following feedingwith 100 m alanine, total
sphingoid base content in the dSpt1C129W expressing animals is
restored back to untreated control levels but is coupled to an
∼8-fold elevation in the free DSB content compared with the ani-
mals grown on normal lab food, conﬁrming a neomorphic effect
following the change in diet. Conﬁrmation of the identity of each
sphingoid base analysed by HPLC is shown in Fig. 3D. Alanine fed
animals globally expressing dSpt1C129W were used to conﬁrm the
identity of the DSB peaks and homozygous dSpt2/laceP hypo-
morphs were used as positive controls to identify endogenous
sphingoid bases in the wild-type traces based on their absence
in dSpt2/laceP samples (previously shown to have a sphingolipid
content of 2.58% (25)). Interestingly, feeding of serine can rescue
Figure 2. Spt1 function is required for appropriate larval nociceptive responses to
rising heat. Targeted Spt1C129W expression under control of the ppk-GAL4 driver in
the class IV da neurons, and global hypomorphic conditions of Spt1 causes
defective nociception similar to that observed during da neuron silencing (ppk-
GAL4 driving expression of UAS-TNTE) and in the painless (pain1) mutant.
****P≤ 0.0001, ANOVA, ns = non-signiﬁcant compared with control.
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Figure 3. Feeding alanine to Spt1C129W expressing ﬂies induces lethality and the appearance of DSBs. (A) Schematic representation of crossing scheme used to produce
Spt1C129W expressing ﬂies and control sibling ﬂies lacking the Spt1C129W transgene for feeding experiments. (B) Feeding of alanine and serine to ﬂies expressing
Spt1C129W or wild-type Spt1. White boxes represent percentage experimental ﬂies surviving, black boxes sibling controls surviving. (C) Quantiﬁcation of total free
endogenous sphingoid base (C14, C16 and C18 sphingosine and sphinganine) and free DSB (C14 deoxysphingosine and deoxysphinganine) content of Drosophila by
HPLC analysis. ****P ≤ 0.0001, two-way ANOVA with Tukey’s multiple comparison test. (D) Representative HPLC traces illustrating identiﬁcation of each peak in the
unknown samples based on known standards (green trace), conﬁrmation of peaks representing endogenous sphingoid bases using the sphingoid base null lace
mutants (black trace) or conﬁrmation of the presence of DSBs via the alanine fed spt1C129W expressing animals (purple trace). Numbers correspond to endogenous free
sphingoid bases, 1 and 2 = C14 chain length sphingosine and sphinganine respectively; 3 and 4 = C16 sphingosine and sphinganine, respectively; 5 and 6 = C18 sphingosine
and sphinganine, respectively. A and B correspond to deoxysphingosine and deoxysphinganine respectively. For all experimental conditions n = 5–8, apart from lacewhere
n = 2. ns = non-signiﬁcant compared with control. (E, F). Disruption of larval synaptic growth parameters at the 6/7 muscle, hemisegment A3 in animals of the genotype
Elav-GAL4/UAS-Spt1C129W, laceP can be rescued by the feeding of serine. Scale bar = 10 µm, ANOVA: F (d.f. 5) = 4.4; P < 0.01, Dunnett’s post hoc comparison to WT (*P < 0.05)
and Bonferroni comparison between groups (##P < 0.01).
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the synaptic development phenotype in an Elav-GAL4, UAS-
dSpt1-C129W, laceP/+ animal (Fig. 3E and F). These data conﬁrm
that dSpt1C129W over-expression in Drosophila acts in a manner
similar to that identiﬁed in the mammalian system (15,16).
Secretory and membrane dysfunction is observed in
sensory neurons expressing dSpt1C129W
During class IV da arbor morphology analysis, accumulations of
mCD8-EGFP ﬂuorescence were observed in neurons expressing
dSpt1C129W that were largely absent in controls (Fig. 4A). It was
considered therefore that, under conditions of altered sphingo-
lipid expression, there is reduced trafﬁcking of mCD8-EGFP out
of the soma into the plasma membrane of the arbor to alter
membrane function. In order to test this theory, ﬂuorescence re-
covery after photobleaching (FRAP)was performed upon dendrite
branches. Figures 4B and C show that FRAP is signiﬁcantly re-
duced in class IV da neurons expressing dSpt1C129W resulting in
a t1/2 (time to half maximal recovery) of 31 s in comparison to
20 s in controls (P < 0.01, Student’s t-test). Co-expression of an
ER marker, Lyz-KDEL-EGFP (33), with Spt1C129W reveals excessive
accumulations of GFP compared with no Spt1C129W expression
(Fig. 4D). These data therefore support the theory that correct
sphingolipid function is required for the correct trafﬁcking of
mCD8-EGFP into the class IV dendrite arbour and that a secretory
deﬁcit is present in neurons expressing dSpt1C129W.
dSpt1C129W or dSpt1 expression in Drosophila larval
sensory neurons generates a subtle arborization defect
With respect to the predominant sensory pathology observed in
HSAN1, we then expressed dSpt1 and dSpt1C129W in the class IV
dendritic arborization (da) neurons using the class IV-speciﬁc
GAL4 driver line pickpocket-GAL4 (ppk-GAL4) (26). Dendritic arbors
were visualized using the co-expression of the plasma mem-
brane marker mCD8-EGFP. Figure 5 shows the dendritic arbour
of the v’ada neuron, in hemisegment 3 proximal to the location
of the muscle 6/7 NMJ. The expression of either dSpt1 or
dSpt1C129W produces a subtle, yet statistically signiﬁcant
reduction in dendrite arborization, as shown by Sholl analysis
(Fig. 5A and B) (27). This subtle alteration in dendritic morph-
ology, at least for the dSpt1C129W expressing neurons may be
due in part to the trafﬁcking deﬁcit of themCD8-EGFPmarker ob-
served in Fig. 4. Together with our data that expression of dSpt1
causes no nociception defect (Fig. 2), we suggest that the pres-
ence of the dSpt1C129W mutation is sufﬁcient to generate deﬁcits
in nociception and that such reductions in function are unlikely
to be caused by changes in dendritic morphology.
Enhancing ER to Golgi trafﬁc rescues dSpt1C129W
expression-induced nociceptive defects
In a genetic screen for mutations affecting sensory dendritic ar-
bour growth, a critical requirement for ER to Golgi trafﬁcking
function was identiﬁed (34). Identiﬁcation of mutations in sec23,
Sar1 and Rab1 suggests that ER to Golgi trafﬁcking function is lim-
iting to dendritic growth (34), a ﬁnding conﬁrmed in mammalian
neurons (35–37). To examine the suggestion that dSpt1C129W ex-
pression may perturb ER to Golgi trafﬁcking affecting sensory
function, we introduced a known effector of ER to Golgi mem-
brane trafﬁcking, Rab1. Figure 5C demonstrates that the co-ex-
pression of the dominantly active form of Rab1Q70L completely
restores the nociceptive defect observed with dSpt1C129W expres-
sion while expression of the constitutively inactive Rab1S25N
Figure 4. Spt1C129W expression in class IV da neurons reduces membrane trafﬁcking to the plasma membrane and induces membrane trafﬁcking defects. (A) Class IV da
neurons expressing themembranemarkermCD8-EGFP and Spt1C129W develop a perinuclear accumulation of EGFP not observed in wild-type animals. (B) FRAP in class IV
daneuron secondary dendrites expressing themembranemarkermCD8-EGFP, driven by the ppk-GAL4 construct is slowerwhen co-expressing Spt1C129W. An area of 45 × 15
pixels was bleached using 100% laser power at 488 nm for 200 iterations and monitored for 200 s. t-half for control dendrites is 20 s (n = 25) and 31 s for cells expressing
SPT1C129W (n = 26) with a signiﬁcant difference of P≤ 0.01. Student’s t-test, t = 2.03, 33 df. (C) Examples of ﬂuorescence recovery inwild-type neurons or neurons expressing
Spt1C129W. Scale bar = 10 µm. (D) Spt1C129W expressing neurons show an accumulation of an ER marker (KDEL-EGFP) in the cell body compared with wild-type. Scale
bar = 10 µm.
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alone phenocopies dSpt1C129W expression. Co-expression of
Rab1S25N with dSpt1C129W in Class IV da neurons causes latency
in the nociceptive response that is no more severe than either
construct alone. Expression of Rab1Q70L generates a dendritic ar-
bour indistinguishable from wild-type. These data together sug-
gest that sphingolipid depletion, or the presence of DSBs, does
indeed induce a trafﬁcking bottle-neck at the ER to Golgi interface
and that this can be circumvented via the expression of ER to
Golgi trafﬁcking effectors, rescuing nociceptor function.
Discussion
HSAN1 is characterized bya deﬁcit in peripheral sensory function
with ulceration and autonomic disturbances (3–5,38). It is unclear
at present why mutations in the globally expressed SPT enzyme
should lead to the speciﬁc peripheral phenotypes of HSAN1. An
initial study suggested themutation conferred a gain-of-function
to the SPT enzyme (7), but later studies in yeast and mammalian
cells (13,14) determined an inhibitory function, albeit with nor-
mal cellular levels of sphingolipids. A more recently proposed
pathologicalmechanism, the presence of DSBs caused by alanine
or glycine incorporation, rather than serine during sphingolipid
synthesis suggests a neomorphic mode of action for the SPTmu-
tations inducing HSAN1 (15,16) if DSBs are indeed toxic (39,40).
These proposed mechanisms are not mutually exclusive, and
the data thatwe presentwith ourDrosophilamodel of HSAN1 sup-
ports both.
For conﬁrmation of the dominant loss-of-function mode of
action of the dSpt1C129W mutant SPT subunit, we assayed the de-
velopment of the larval NMJ. The lace locus in Drosophila encodes
the dSpt2 enzyme (21). The lacePmutant is a hypomorphic trans-
poson insertion in the dSpt2 locus that as a homozygote dies early
in the pupal stage of development (21) and has been shown to ex-
press 2.58% of wild-type sphingolipid levels (25). Figure 1C and D
shows that in the lacemutant, muscle 6/7 NMJ is severely under-
developed in terms of bouton number, the observed boutons
being larger and fewer than wild-type animals. This is the ﬁrst
description of a sphingolipid deﬁcient synapse and suggests
that these complex lipids are essential for regulation of synaptic
structure. Similarly, expressing dSpt1C129W under the control of
Elav-GAL4 neuronal promoter produces an aberrant develop-
mental phenotype though not as severe. Introduction of dSpt1
or dSpt2/laceP heterozygous loss-of-function alleles in the pres-
ence of globally or neuronally expressed dSpt1C129W cause, re-
spectively, early lethality and a synaptic phenotype identical to
the dSpt2/laceP loss-of-function mutant. This phenocopy sup-
ports our sphingolipid quantiﬁcation data shown in Fig. 3,
suggesting that dSpt1C129W expression reduces sphingolipid
Figure 5. Increased ER–Golgi membrane trafﬁcking rescues Spt1C129W-induced nociception defects. (A) Exhaustive Z-stack confocal images of the v’ada class IV da sensory
neurons in larval hemisegment A3 of larvae expressing mCD8-EGFP under control of the ppk-GAL4 driver in combination with UAS-Spt1, UAS-Spt1C129W, UAS-Rab1Q70L or
UAS-Rab1S25N. Scale bar = 10 µm. (B) Sholl analysis performed on dendrite traces reveals that Spt1 or Spt1C129W expression mildly, yet signiﬁcantly, reduces arborization.
Kolmogorov–Smirnov test, **P < 0.05, z = 1.436. (C) Co-expression of dominant-active Rab1Q70L signiﬁcantly rescues Spt1C129W-expression-induced defective nociception.
Expression of Rab1Q70L increases larval sensitivity to noxious heat, whereas expression of dominant-negative Rab1S25N causes defective nociception equivalent to that
induced by Spt1C129W expression. Co-expression of UAS-Spt1C129W and UAS-Rab1S25N does not signiﬁcantly worsen the nociceptive defect. ***P ≤ 0.001, ****P ≤ 0.0001,
ANOVA, ns = non-signiﬁcant compared with control.
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biogenesis consistent with the early reports of a dominant-nega-
tivemutant function (13,14). Reduction ofwild-type copy number
of dSpt1 or dSpt2/lace subunits of dSpt in the presence of the
dSpt1C129W mutant induces a severe phenotype identical to a
strong dSpt2 hypomorphicmutation with a very low sphingolipid
content. These genetic combinations conﬁrm the potential dom-
inant-negative mode of action for the disease mutation in a per-
ipheral neuron in our system.
Expression of dSpt1C129W in the class IV md sensory neurons
responsible for thermo- and mechanosensory function in Dros-
ophila larvae (28,41,42) induces a mild morphological reduction
in dendrite terminals consistent with loss of epidermal innerv-
ation in SPT1C133W/Y carrying HSAN1 patients (5,43). These larvae
also display a deﬁcit in thermosensation, showing a latency to re-
spond to rising temperature consistent with a lack of function in
the class IVmdneurons. Interestingly, optogenetic stimulation of
the class IVmdneurons in the presence of the dSpt1C129Wmutant
can still elicit a nocifensive response (Supplementary Material,
Movie S1) indicating some synaptic function remains in these
compromised neurons. Synaptic structure of Class IV da neurons
in the ventral nerve cord is preserved when dSpt1C129W is ex-
pressed (Supplementary Material, Fig. S2). These data suggest
that the functional deﬁcit may not centre on synaptic function
in dSpt1C129W compromised sensory neurons but may lie in the
dendritic arbour.
On examination of larval sensory neurons expressing
dSpt1C129W, we observed a membrane trafﬁcking deﬁcit in cell
soma. The data presented here, an expression of constitutively
active Rab1 rescue of a dSpt1C129W-induced sensory deﬁcit, sug-
gests that dSpt1C129Wexpression induces an ER to Golgi trafﬁcking
restriction and that this disrupts nociception. Recent reports sug-
gest a novel activity for the SPTenzyme bearing themutated sub-
unit. The C133W mutation is proposed to confer a preferred
speciﬁcity for alanine over serine in the condensation reaction
between serine and palmitoyl-CoA (15,16) to generate DSBs, a
ﬁnding conﬁrmed in this study with the alanine fed dSpt1C129W
expressing animal. In this scheme, it is proposed that the DSBs
generate stress in the ER (16) and defects in neurite outgrowth
and retraction (15). Membrane biogenesis is critically dependent
on the orchestration between lipid and protein synthesis at the
ER. Export of protein complexes from the ER can be dependent
on the availability of ceramide (44), while the export of GPI-an-
chored proteins are critically dependent on the presence of
sphingolipids and sterols (45,46). Disruption of the ORM1/2 pro-
teins, important regulators of SPT function, leads to severe de-
fects in ER function with a slowed ER-to-Golgi transport (47).
Dendrites are particularly rich in components of the secretory ap-
paratus with ER export sites and Golgi outposts assembled regu-
larly throughout the dendritic tree (48–50). A genetic screen in
Drosophila larvae, using the growth of the class IV md neurons
as a model identiﬁed factors of ER-to-Golgi trafﬁc as essential
for proper dendritic growth (34). Studies in mammalian growing
neurites conﬁrm this requirement (35,36), suggesting a critical re-
liance in dendrites for secretory function. ER export sites are es-
sential for dendrite outgrowth, but they are also observed to
recruit neurotransmitter receptors uponmetabotropic activation
andneuronal activity reﬂecting a potential role in regulating den-
dritic function (35,48). Recent identiﬁcation of dominant muta-
tions in Atlastin1 and 3, proteins required for homotypic
membrane fusion in the ER, in HSAN1 patients (51–54) similarly
point to ER function as a ‘pinch-point’ in distal peripheral sen-
sory function.
Oral supplementation of -serine to the diet of mSPT1C133W
expressing mice decreased DSB levels in plasma, paralleling
similar observations in SPT1C133W carrying HSAN1 patients (55).
We observe a similar effect in our Drosophila model system with
alanine feeding to dSpt1C129W expressing animals inducing le-
thality that can be partially rescued by supplementation of -ser-
ine in the food source. We also ﬁnd that we can rescue synaptic
structure in an Elav-GAL4/UAS-dSptC129W, laceP animal by feeding
serine in the diet suggesting that the potential dominant-nega-
tive action of dSptC129W may be due to incorporation of alanine
in nascent sphingolipids.
Wehave demonstrated that the causativemutation ofHSAN1,
SPT1C133Wwhen expressed inDrosophila (as dSpt1C129W) acts dom-
inantly to reduce sphingolipid synthesis, generate synthesis of
DSBs and perturb the development of dendrites, neuromuscular
synapses andnociceptive function of the class IV da sensory neu-
rons. This reveals an essential function of sphingolipids in the
development of these neurons in vivo. We also demonstrate
that the expression of dSpt1C129W causes a signiﬁcant reduction
in the sensitivity of third instar larvae to noxious heat stimuli,
producing a phenotype consistent with that observed in HSAN1
patients. Our data reveal that this sensory dysfunction may be
due to an aberrant trafﬁcking bottle-neck in sensory dendrites,
consistent with dysfunction in the ER. Thus we present a novel
mechanism for the pathology observed in HSAN1 due to muta-
tions in SPT1 in a simple model system amenable that recapitu-
lates many aspects of the human disease.
Materials and Methods
Drosophila stocks and husbandry
Drosophila maintenance and crosses were performed using
standard yeast–agar media at 25°C. Stocks used in this study:
UAS-dSpt1C129W, UAS-Spt1 (this study), UAS-ChRh2 (56) (Gero
Miesenböck, Oxford), UAS-LYZ-GFP-KDEL (33) (Mary Lilly, NIH,
Bethesda), UAS-Tetanus-toxin (29), pain1 (28) (Dan Tracey,
Durham, NC), laceP (21) (John Roote, Cambridge), SPT1l(2)SH1626
(19) (Stephen Hou, NIH, Bethesda), pickpocket-GAL4 (26) (Wes
Grueber, Columbia). The following stocks were obtained from
the Bloomington Stock Centre, Indiana: w1118 (used throughout
as wild-type), Df(2R)Vg-B, Elav-GAL4 tubulin-GAL4, UAS-mCD8-
GFP, UAS-YFP-Rab1Q70L, UAS-YFP-Rab1S25N (57), l(2)49Fb1, l(2)
49Fb4 (20).
Generation of UAS-dSpt1 andUAS-dSpt1C129W transgenes
The C129W mutation was introduced into the dSpt1 cDNA
(RE58623) by site-directed-mutagenesis using the following
forward (CGGAGTTGGATCTTGGGGACCTCGG) and reverse (CCG
AGGTCCCCAAGATCCAACCTCCG) primers. Each construct was
then sequence-veriﬁed and cloned into pUASt (22). Microinjec-
tion into w- embryos was then carried out using standard
procedures.
NMJ analysis
Third instar wandering larvaewere dissected in PBS, ﬁxed in 3.7%
formaldehyde/PBS for 7 min and stained using the appropriate
primary antibodies, Cy3 conjugated goat anti-HRP (1:200, Stra-
tech scientiﬁc); rabbit anti-synaptotagmin (1:2000) (58). Synaptic
bouton numbers at muscles 6/7, hemisegment A3, were deter-
mined by counting each distinct, spherical, anti-synaptotagmin
positive varicosity contacting the muscle. As synaptic bouton
number has been shown to increase proportionally with muscle
surface area (MSA) synaptic bouton numbers were normalized
against MSA by dividing the bouton number by the MSA and
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multiplying bymeanwild-typeMSA as described by (59). Muscles
and synapses were imaged using an AxioCam HRC camera on a
Axiovert 200 invert ﬂuorescencemicroscope using Plan-NeoFluar
10×/0.3 and 40×/0.75 lenses, with Axiovision Rel. 4.8 software.
Measurements were made from images using ImageJ.
Dendritic arbour morphology
Third instar larvae were dissected, and mounted. Dendritic ﬁeld
imaging was performed using a CarlZeiss Axiovert 200M inverted
confocalmicroscopewith a 20× objective lens. High power excita-
tionwavelength (488 nm) light and exhaustive Z-stack conditions
were used to image the v’ ada class IV da neuron. Neurons were
traced using NeuronJ imageJ plugin (60). Sholl analysis (27) was
then performed upon these tracings using the Sholl analysis Im-
ageJ plugin (62). Cumulative branch distribution data were inter-
rogated using the Kolmogorov–Smirnov test, n > 5.
Sphingolipid quantiﬁcation
Larvae were rapidly dissected in cold PBS to remove the fat bod-
ies and subsequently frozen. After homogenization 1 mg was
taken and used for each extraction. Total sphingolipids were
extracted overnight in chloroform:methanol (1:1), and sample
cleanup, labelling with o-phthalaldehyde and analysis by
HPLC were as described previously (61). Standards of C14 and
C16 sphingoid bases were from Matreya, C18 sphingoid bases
were from Sigma and an internal control C20 sphingosine was
from Avanti Polar Lipids.
Larval nociception analysis
Third instar nociception assay baseduponnocifensive character-
istic escape behaviours to heat (17,28). Wandering third instar
larvae were placed into a 30-μl water droplet on a petri dish.
The petri dish was then placed onto a standard heater block set
to 70°C. The time taken to perform escape behaviour was re-
corded, with respect to the ﬁrst violent head-swing. Droplet tem-
perature calibration was measured using a thermocouple with a
digital read-out (Tenma 72-2060, Tenma Test Equipment Ohio,
USA), held into the water droplet (n > 20). Nociception data inter-
rogated using one-way ANOVA (n > 15). Nociception movies were
recorded using a standard WebCam suspended above the heater
block.
Secondary dendrite ﬂuorescence resonance analysis
after photobleaching imaging
Live larval dissection was performed as described for NMJ ana-
lysis above with the exception that experiments were performed
in physiological saline. Speciﬁcally, wandering third-instar lar-
vae were selected and were recorded in HL3 saline (70 m NaCl,
5 m KCl, 10 m NaHCO3, 115 m sucrose, 5 m trehalose and
5 m HEPES) with 0.4 m Ca2+. Class IV da neurons were located
using CarlZeiss Axiovert 200M inverted confocalmicroscopewith
a 63× objective lens. The 100% laser power (488 nm, 20 mW) for
200 iterations was used to bleach region of interest 1 (ROI1) fol-
lowed by 200 s post-bleach imaging to observe recovery. Acquisi-
tional bleaching was controlled for using a second ROI and the
following equation ((ROI1/ROI2)/(t = 0ROI1/t = 0ROI2)) * 100 =% re-
covery (t = 0, pre-bleach ﬂuorescence) (n > 25). Highmagniﬁcation
images of class IV da neuron cell bodies and muscle 6/7 NMJs
were made using a CarlZeiss Axiovert 200M inverted confocal
microscope with a 63× objective lens.
Alanine and serine feeding
Drosophila instant food (Carolina Biological Supply) was reconsti-
tuted using distilled water supplemented with -serine or -ala-
nine. Drosophila crosses were added directly to this food source
and allowed to lay for 3 days. Resultant offspring were counted
and noted for genetic markers to assess survival. Crosses used
were: (1) wild-type – w1118, (2) tubulin-GAL4/TM6b, Hu, Tbx UAS-
dSpt1C129W and (3) tubulin-GAL4/TM6b, Hu, Tb x UAS-dSpt1.
Supplementary Material
Supplementary Material is available at HMG online.
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